CRBP vs. HSBC
Compare and contrast key facts about Corbus Pharmaceuticals Holdings, Inc. (CRBP) and HSBC Holdings plc (HSBC).
Performance
CRBP vs. HSBC - Performance Comparison
Loading graphics...
CRBP vs. HSBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRBP Corbus Pharmaceuticals Holdings, Inc. | 22.60% | -31.02% | 95.36% | 82.20% | -82.05% | -50.74% | -77.11% | -6.51% | -17.75% | -15.98% |
HSBC HSBC Holdings plc | 11.69% | 67.91% | 34.48% | 39.45% | 7.79% | 20.76% | -31.71% | 1.44% | -16.05% | 36.04% |
Fundamentals
CRBP:
$132.90M
HSBC:
$300.97B
CRBP:
-$6.22
HSBC:
$6.36
CRBP:
0.90
HSBC:
1.70
CRBP:
$0.00
HSBC:
$147.86B
CRBP:
$0.00
HSBC:
$80.78B
CRBP:
$0.00
HSBC:
$29.03B
Returns By Period
In the year-to-date period, CRBP achieves a 22.60% return, which is significantly higher than HSBC's 11.69% return. Over the past 10 years, CRBP has underperformed HSBC with an annualized return of -15.54%, while HSBC has yielded a comparatively higher 17.26% annualized return.
CRBP
- 1D
- 6.28%
- 1M
- 19.52%
- YTD
- 22.60%
- 6M
- -23.47%
- 1Y
- 98.41%
- 3Y*
- 11.14%
- 5Y*
- -30.49%
- 10Y*
- -15.54%
HSBC
- 1D
- 3.60%
- 1M
- -2.08%
- YTD
- 11.69%
- 6M
- 23.99%
- 1Y
- 57.09%
- 3Y*
- 46.04%
- 5Y*
- 31.66%
- 10Y*
- 17.26%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRBP vs. HSBC — Risk / Return Rank
CRBP
HSBC
CRBP vs. HSBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corbus Pharmaceuticals Holdings, Inc. (CRBP) and HSBC Holdings plc (HSBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CRBP | HSBC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.26 | 2.03 | -0.77 |
Sortino ratioReturn per unit of downside risk | 1.96 | 2.51 | -0.55 |
Omega ratioGain probability vs. loss probability | 1.26 | 1.37 | -0.11 |
Calmar ratioReturn relative to maximum drawdown | 1.42 | 2.91 | -1.49 |
Martin ratioReturn relative to average drawdown | 2.53 | 10.63 | -8.11 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| CRBP | HSBC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.26 | 2.03 | -0.77 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.19 | 1.24 | -1.44 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.12 | 0.68 | -0.80 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.14 | 0.24 | -0.38 |
Correlation
The correlation between CRBP and HSBC is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
CRBP vs. HSBC - Dividend Comparison
CRBP has not paid dividends to shareholders, while HSBC's dividend yield for the trailing twelve months is around 4.39%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRBP Corbus Pharmaceuticals Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HSBC HSBC Holdings plc | 4.39% | 4.19% | 8.29% | 6.54% | 4.33% | 3.65% | 4.05% | 6.52% | 6.20% | 4.94% | 6.35% | 6.33% |
Drawdowns
CRBP vs. HSBC - Drawdown Comparison
The maximum CRBP drawdown since its inception was -99.31%, which is greater than HSBC's maximum drawdown of -74.47%. Use the drawdown chart below to compare losses from any high point for CRBP and HSBC.
Loading graphics...
Drawdown Indicators
| CRBP | HSBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.31% | -74.47% | -24.84% |
Max Drawdown (1Y)Largest decline over 1 year | -61.83% | -19.48% | -42.35% |
Max Drawdown (5Y)Largest decline over 5 years | -96.77% | -31.80% | -64.97% |
Max Drawdown (10Y)Largest decline over 10 years | -99.31% | -62.26% | -37.05% |
Current DrawdownCurrent decline from peak | -96.79% | -7.02% | -89.77% |
Average DrawdownAverage peak-to-trough decline | -65.54% | -24.26% | -41.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.83% | 5.33% | +29.50% |
Volatility
CRBP vs. HSBC - Volatility Comparison
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a higher volatility of 28.46% compared to HSBC Holdings plc (HSBC) at 10.76%. This indicates that CRBP's price experiences larger fluctuations and is considered to be riskier than HSBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| CRBP | HSBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.46% | 10.76% | +17.70% |
Volatility (6M)Calculated over the trailing 6-month period | 60.01% | 20.67% | +39.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.45% | 28.22% | +50.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 158.81% | 25.57% | +133.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 128.84% | 25.49% | +103.35% |
Financials
CRBP vs. HSBC - Financials Comparison
This section allows you to compare key financial metrics between Corbus Pharmaceuticals Holdings, Inc. and HSBC Holdings plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities